Clinical trial
The Effectiveness of Single or Repeat Zoledronate Infusion Versus Oral Alendronate in Consolidating the Bone Accrual Achieved With Denosumab: a Study Organised by the European Calcified Tissue Society
NCT05575167 is registered in ClinicalTrials.gov with 424 General Military Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effectiveness of Single or Repeat Zoledronate Infusion Versus Oral Alendronate in Consolidating the Bone Accrual Achieved With Denosumab: a Study Organised by the European Calcified Tissue Society
- Lead sponsor
- 424 General Military Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 28, 2023
- Completion date
- November 30, 2027
- Enrollment
- 122 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.